177 related articles for article (PubMed ID: 21162536)
1. New potential anticancer agent of carborane derivatives: selective cellular interaction and activity of ferrocene-substituted dithio-o-carborane conjugates.
Wu C; Ye H; Bai W; Li Q; Guo D; Lv G; Yan H; Wang X
Bioconjug Chem; 2011 Jan; 22(1):16-25. PubMed ID: 21162536
[TBL] [Abstract][Full Text] [Related]
2. Ferrocene-substituted dithio-o-carborane isomers: influence on the native conformation of myoglobin protein.
Wu C; Xu B; Zhao J; Jiang Q; Wei F; Jiang H; Wang X; Yan H
Chemistry; 2010 Aug; 16(29):8914-22. PubMed ID: 20572183
[TBL] [Abstract][Full Text] [Related]
3. [Fluorescence spectroscopic study on the biointeraction of new organometallic carborane derivatives with bovine serum albumin].
Wu CH; Ye HD; Wu DH; Yan H; Wang XM; Chen J
Guang Pu Xue Yu Guang Pu Fen Xi; 2013 Jan; 33(1):120-5. PubMed ID: 23586239
[TBL] [Abstract][Full Text] [Related]
4. New cytotoxic rosamine derivatives selectively accumulate in the mitochondria of cancer cells.
Lim SH; Wu L; Burgess K; Lee HB
Anticancer Drugs; 2009 Jul; 20(6):461-8. PubMed ID: 19387338
[TBL] [Abstract][Full Text] [Related]
5. m-Carborane bisphenol structure as a pharmacophore for selective estrogen receptor modulators.
Ogawa T; Ohta K; Yoshimi T; Yamazaki H; Suzuki T; Ohta S; Endo Y
Bioorg Med Chem Lett; 2006 Aug; 16(15):3943-6. PubMed ID: 16735120
[TBL] [Abstract][Full Text] [Related]
6. Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure.
Sun RW; Li CK; Ma DL; Yan JJ; Lok CN; Leung CH; Zhu N; Che CM
Chemistry; 2010 Mar; 16(10):3097-113. PubMed ID: 20162647
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of hydroxyl-substituted Schiff-bases containing ferrocenyl moieties.
Chen W; Ou W; Wang L; Hao Y; Cheng J; Li J; Liu YN
Dalton Trans; 2013 Nov; 42(44):15678-86. PubMed ID: 24048480
[TBL] [Abstract][Full Text] [Related]
8. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
Chari RV
Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of a series of ferrocene-containing beta-diketones.
Swarts JC; Vosloo TG; Cronje SJ; Du Plessis WC; Van Rensburg CE; Kreft E; Van Lier JE
Anticancer Res; 2008; 28(5A):2781-4. PubMed ID: 19035310
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro biological evaluation of new polyamine conjugates as potential anticancer drugs.
Szumilak M; Szulawska-Mroczek A; Koprowska K; Stasiak M; Lewgowd W; Stanczak A; Czyz M
Eur J Med Chem; 2010 Dec; 45(12):5744-51. PubMed ID: 20974504
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, cytotoxic activities and cell cycle arrest profiles of half-sandwich N-sulfonamide based dithio-o-carborane metal complexes.
Dou H; Zhong W; Yang L; Wang T; Yan H; Hou Y
Bioorg Med Chem; 2012 Aug; 20(15):4693-700. PubMed ID: 22763368
[TBL] [Abstract][Full Text] [Related]
12. Structure--activity relationship and mode of action of N-(6-ferrocenyl-2-naphthoyl) dipeptide ethyl esters: novel organometallic anticancer compounds.
Mooney A; Tiedt R; Maghoub T; O'Donovan N; Crown J; White B; Kenny PT
J Med Chem; 2012 Jun; 55(11):5455-66. PubMed ID: 22548380
[TBL] [Abstract][Full Text] [Related]
13. Dinuclear copper(I) complexes containing cyclodiphosphazane derivatives and pyridyl ligands: synthesis, structural studies, and antiproliferative activity toward human cervical and breast cancer cells.
Balakrishna MS; Suresh D; Rai A; Mague JT; Panda D
Inorg Chem; 2010 Oct; 49(19):8790-801. PubMed ID: 20812680
[TBL] [Abstract][Full Text] [Related]
14. Ligand-based neutral ruthenium(II) arene complex: selective anticancer action.
Wu CH; Wu DH; Liu X; Guoyiqibayi G; Guo DD; Lv G; Wang XM; Yan H; Jiang H; Lu ZH
Inorg Chem; 2009 Mar; 48(6):2352-4. PubMed ID: 19220049
[TBL] [Abstract][Full Text] [Related]
15. Quinazolinone linked pyrrolo[2,1-c][1,4]benzodiazepine (PBD) conjugates: Design, synthesis and biological evaluation as potential anticancer agents.
Kamal A; Vijaya Bharathi E; Janaki Ramaiah M; Dastagiri D; Surendranadha Reddy J; Viswanath A; Sultana F; Pushpavalli SN; Pal-Bhadra M; Srivastava HK; Narahari Sastry G; Juvekar A; Sen S; Zingde S
Bioorg Med Chem; 2010 Jan; 18(2):526-42. PubMed ID: 20031423
[TBL] [Abstract][Full Text] [Related]
16. Antineoplastic activity of a series of ferrocene-containing alcohols.
Shago RF; Swarts JC; Kreft E; Van Rensburg CE
Anticancer Res; 2007; 27(5A):3431-3. PubMed ID: 17970091
[TBL] [Abstract][Full Text] [Related]
17. Iminosugar-ferrocene conjugates as potential anticancer agents.
Hottin A; Dubar F; Steenackers A; Delannoy P; Biot C; Behr JB
Org Biomol Chem; 2012 Aug; 10(29):5592-7. PubMed ID: 22717621
[TBL] [Abstract][Full Text] [Related]
18. Ferrocenoyl pyridine arene ruthenium complexes with anticancer properties: synthesis, structure, electrochemistry, and cytotoxicity.
Auzias M; Therrien B; Süss-Fink G; Stepnicka P; Ang WH; Dyson PJ
Inorg Chem; 2008 Jan; 47(2):578-83. PubMed ID: 18085776
[TBL] [Abstract][Full Text] [Related]
19. Potent androgen antagonists based on carborane as a hydrophobic core structure.
Fujii S; Goto T; Ohta K; Hashimoto Y; Suzuki T; Ohta S; Endo Y
J Med Chem; 2005 Jul; 48(14):4654-62. PubMed ID: 16000001
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, structure, and biological activity of ferrocenyl carbohydrate conjugates.
Ferreira CL; Ewart CB; Barta CA; Little S; Yardley V; Martins C; Polishchuk E; Smith PJ; Moss JR; Merkel M; Adam MJ; Orvig C
Inorg Chem; 2006 Oct; 45(20):8414-22. PubMed ID: 16999442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
